KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Amortization - Intangibles (2019 - 2025)

Historic Amortization - Intangibles for Supernus Pharmaceuticals (SUPN) over the last 7 years, with Q3 2025 value amounting to $24.3 million.

  • Supernus Pharmaceuticals' Amortization - Intangibles rose 2474.36% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.2 million, marking a year-over-year increase of 294.7%. This contributed to the annual value of $78.0 million for FY2024, which is 533.98% down from last year.
  • According to the latest figures from Q3 2025, Supernus Pharmaceuticals' Amortization - Intangibles is $24.3 million, which was up 2474.36% from $20.8 million recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Amortization - Intangibles peaked at $24.3 million during Q3 2025, and registered a low of $5.9 million during Q2 2021.
  • Its 5-year average for Amortization - Intangibles is $17.8 million, with a median of $20.1 million in 2023.
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first surged by 36207.69% in 2021, then crashed by 1336.08% in 2024.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Amortization - Intangibles stood at $12.0 million in 2021, then soared by 71.97% to $20.7 million in 2022, then rose by 1.86% to $21.1 million in 2023, then decreased by 13.36% to $18.3 million in 2024, then soared by 33.16% to $24.3 million in 2025.
  • Its last three reported values are $24.3 million in Q3 2025, $20.8 million for Q2 2025, and $19.8 million during Q1 2025.